TANGO THERAPEUTICS, INC.

Analyst Reco. Tango Therapeutics, Inc.

Equities

TNGX

US87583X1090

Real-time Estimate Cboe BZX Other stock markets 12:03:21 2024-05-30 pm EDT			5-day change	1st Jan Change
6.63 ^USD	-1.78%		-5.50%	-32.32%

May. 28	HC Wainwright Adjusts Price Target on Tango Therapeutics to $13 From $17, Maintains Buy Rating	MT
May. 24	Guggenheim Adjusts Tango Therapeutics Price Target to $14 From $16, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Tango Therapeutics to $13 From $17, Maintains Buy Rating	May. 28	MT
Guggenheim Adjusts Tango Therapeutics Price Target to $14 From $16, Maintains Buy Rating	May. 24	MT
Barclays Adjusts Tango Therapeutics Price Target to $13 From $18, Maintains Overweight Rating	May. 24	MT
Wedbush Adjusts Tango Therapeutics Price Target to $11 From $18, Maintains Outperform Rating	May. 23	MT
Cantor Fitzgerald Initiates Coverage on Tango Therapeutics With Overweight Rating	Apr. 04	MT
H.C. Wainwright Adjusts Price Target on Tango Therapeutics to $17 From $16, Keeps Buy Rating	Mar. 20	MT
Piper Sandler Initiates Tango Therapeutics With Overweight Rating	Feb. 12	MT
B. Riley Starts Tango Therapeutics With Buy Rating, $16 Price Target	Dec. 08	MT
HC Wainwright Adjusts Tango Therapeutics Price Target to $16 From $11, Maintains Buy Rating	23-08-11	MT
Wedbush Lowers Tango Therapeutics' Price Target to $18 From $21, Updates Model After Q4 Results; Keeps Outperform Rating	23-03-28	MT
HC Wainwright Adjusts Price Target on Tango Therapeutics to $11 From $10, Maintains Buy Rating	23-03-28	MT
Wedbush Lifts Tango Therapeutics' Price Target to $21 From $20, Keeps Outperform Rating	22-11-11	MT
HC Wainwright Starts Tango Therapeutics at Buy with $10 Price Target	22-10-20	MT
Guggenheim Adjusts Tango Therapeutics' Price Target to $14 from $16, Keeps Buy Rating	22-03-29	MT
TANGO THERAPEUTICS : SVB Leerink Initiates Coverage on Tango Therapeutics With Outperform Rating, $25 Price Target	21-09-20	MT
TANGO THERAPEUTICS : Guggenheim Starts Tango Therapeutics at Buy with $16 Price Target	21-09-07	MT
TANGO THERAPEUTICS : Barclays Initiates Tango Therapeutics With Overweight Rating, $18 Price Target	21-09-07	MT
TANGO THERAPEUTICS : Wedbush Initiates Tango Therapeutics With Outperform Rating, $20 Price Target	21-09-07	MT
TANGO THERAPEUTICS : Goldman Sachs Initiates Tango Therapeutics With Buy Rating, $17 Price Target	21-09-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer